Pharmaceutical company AstraZeneca has commissioned Herzog & de Meuron
to design its new headquarters in Cambridge, United Kingdom. A central hub of labs will serve as the focal point of the development, which aims to promote collaboration among employees through an open design and campus environment. The project also will feature a global research and development center.
“We want to create a site that supports our ambition of achieving scientific leadership while blending into the fabric of the thriving local scientific community,” Mene Pangalos, executive vice president, Innovative Medicines & Early Development at AstraZeneca, said in a statement. “We believe Herzog & de Meuron is the right firm to help us do this, with a great deal of relevant experience in developing functional, modern workplaces and pharmaceutical research facilities.”
The architects will integrate Cambridge’s tradition of low-rise architecture and internal courtyards into the design of the headquarters. “Our response to the brief includes intimate spaces for concentration and work, as well as common spaces where everyone meets and comes together,” said Pierre de Meuron, senior partner at Herzog & de Meuron. “The center will be a great place for AstraZeneca to work and exchange with the local community of scientists, students, and visitors.”